hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis

Wei,Dongshan; Sun,Lifang; Feng,Wei

doi:10.3892/mmr.2021.12109

hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis

Authors:
- Dongshan Wei
- Lifang Sun
- Wei Feng
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China, Department of Tuberculosis, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China, Department of Cancer Diagnosis and Treatment, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310000, P.R. China
Published online on: April 20, 2021 https://doi.org/10.3892/mmr.2021.12109
Article Number: 470
Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Abnormal circular RNAs (circRNAs) are associated with biological processes in cancer; however, the function of circRNAs remains largely unknown in non‑small cell lung cancer (NSCLC). The present study aimed to investigate the role of hsa_circ_0058357 on the progression of NSCLC. Cell proliferation, migration and apoptosis were determined using Cell Counting Kit‑8, Transwell and flow cytometry assays, respectively. Gene [circRNA and microRNA (miR)] and protein expression levels were determined via reverse transcription‑quantitative PCR and immunoblotting. A luciferase assay was employed to detect the binding of miR‑24‑3p with AVL9 cell migration associated (AVL9), while a cancer xenograft model was established to evaluate cancer growth in vivo. The results demonstrated that hsa_circ_0058357 was highly expressed in human NSCLC tissues and NSCLC cells compared with para‑cancerous tissues and human bronchial epithelial (HBE) cells, respectively. Knockdown of hsa_circ_0058357 significantly suppressed cell viability, migration and tumor growth, while it promoted apoptosis in NSCLC cells. As a competing endogenous RNA, hsa_circ_0058357 knockdown contributed to the increase of miR‑24‑3p expression in NSCLC cells. Of note, overexpression of miR‑24‑3p markedly abolished the exogenous hsa_circ_0058357‑induced excessive proliferation, migration and apoptosis resistance of NSCLC cells. Mechanistically, as a signaling molecule in late secretory pathway, AVL9 was also expressed at a high level in NSCLC tissues and cells, which could be directly suppressed by miR‑24‑3p. In the tumor tissues, along with growth inhibition, hsa_circ_0058357 knockdown also mediated the elevation of miR‑24‑3p and the reduction of AVL9. Thus, it was suggested that hsa_circ_0058357 may be a crucial regulation factor in NSCLC by sponging hsa‑miR‑24‑3p, leading to a decrease in miR‑24‑3p expression, and subsequent increase in AVL9 expression. Therefore, hsa_circ_0058357 may serve as a potential target for diagnosis and gene therapy for NSCLC.

View Figures

View References

1	Zheng HM, Zhan YT, Liu SL, Lu J, Luo J, Feng J and Fan S: The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications. J Exp Clin Canc Res. 37:2262018. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
3	Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, Buchan JR and Cho WC: Role of autophagy and apoptosis in non-small-cell lung cancer. Int J Mol Sci. 18:3672017. View Article : Google Scholar : PubMed/NCBI
4	Rong B, Nan Y, Liu H and Gao W: Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer. Cancer Biomark. 19:35–43. 2017. View Article : Google Scholar : PubMed/NCBI
5	Liu ZL, Zhu WR, Zhou WC, Ying HF, Zheng L, Guo YB, Chen JX and Shen XH: Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: A systematic review and meta-analysis. J Integr Med. 12:346–358. 2014. View Article : Google Scholar : PubMed/NCBI
6	Gupta GP and Massague J: Cancer metastasis: Building a framework. Cell. 127:679–695. 2006. View Article : Google Scholar : PubMed/NCBI
7	Cui J, Li W, Liu G, Chen X, Gao X, Lu H and Lin D: A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f. Artif Cells Nanomed Biotechnol. 47:810–821. 2019. View Article : Google Scholar : PubMed/NCBI
8	Xie G: Circular RNA hsa-circ-0012129 promotes cell proliferation and invasion in 30 cases of human glioma and human glioma cell lines U373, A172, and SHG44, by targeting MicroRNA-661 (miR-661). Med Sci Monit. 24:2497–2507. 2018. View Article : Google Scholar : PubMed/NCBI
9	Zhang Z, Yu K, Liu O, Xiong Y, Yang X, Wang S, Zhang S, Feng Y and Peng Y: Expression profile and bioinformatics analyses of circular RNAs in keloid and normal dermal fibroblasts. Exp Cell Res. 388:1117992020. View Article : Google Scholar : PubMed/NCBI
10	Yu W, Jiang H, Zhang H and Li J: Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer. Onco Targets Ther. 11:5569–5577. 2018. View Article : Google Scholar : PubMed/NCBI
11	Liu C, Zhang Z and Qi D: Circular RNA hsa_circ_0023404 promotes proliferation, migration and invasion in non-small cell lung cancer by regulating miR-217/ZEB1 axis. Onco Targets Ther. 12:6181–6189. 2019. View Article : Google Scholar : PubMed/NCBI
12	Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018. View Article : Google Scholar : PubMed/NCBI
13	Zhang L, Nebane NM, Wennerberg K, Li Y, Neubauer V, Hobrath JV, McKellip S, Rasmussen L, Shindo N, Sosa M, et al: A high-throughput screen for chemical inhibitors of exocytic transport in yeast. Chembiochem. 11:1291–1301. 2010. View Article : Google Scholar : PubMed/NCBI
14	Harsay E and Schekman R: Avl9p, a member of a novel protein superfamily, functions in the late secretory pathway. Mol Biol Cell. 18:1203–1219. 2007. View Article : Google Scholar : PubMed/NCBI
15	Li Y, Xu J, Xiong H, Ma Z, Wang Z, Kipreos ET, Dalton S and Zhao S: Cancer driver candidate genes AVL9, DENND5A and NUPL1 contribute to MDCK cystogenesis. Oncoscience. 1:854–865. 2014. View Article : Google Scholar : PubMed/NCBI
16	Tang J, Li Y, Lyon K, Camps J, Dalton S, Ried T and Zhao S: Cancer driver-passenger distinction via sporadic human and dog cancer comparison: A proof-of-principle study with colorectal cancer. Oncogene. 33:814–822. 2014. View Article : Google Scholar : PubMed/NCBI
17	Wang H, Yu M, Hu W, Chen X, Luo Y, Lin X, Zeng Y and Yao X: Linc00662 promotes tumorigenesis and progression by regulating miR-497-5p/AVL9 axis in colorectal cancer. Front Genet. 10:13852020. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Olbromski M, Rzechonek A, Grzegrzolka J, Glatzel-Plucinska N, Chachaj A, Werynska B, Podhorska-Okolow M and Dziegiel P: Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma. Oncol Rep. 39:201–208. 2018.PubMed/NCBI
20	Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S and Yuan H: Microarray profile of circular RNAs identifies hsa_circ_0014130 as a new circular RNA biomarker in non-small cell lung cancer. Sci Rep. 8:28782018. View Article : Google Scholar : PubMed/NCBI
21	Qu D, Yan B, Xin R and Ma T: A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res. 8:1387–1402. 2018.PubMed/NCBI
22	Zhu X, Wang X, Wei S, Chen Y, Chen Y, Fan X, Han S and Wu G: hsa_circ_0013958: A circular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J. 284:2170–2182. 2017. View Article : Google Scholar : PubMed/NCBI
23	Li J, Wang J, Chen Z, Chen Y and Jin M: Hsa_circ_0079530 promotes cell proliferation and invasion in non-small cell lung cancer. Gene. 665:1–5. 2018. View Article : Google Scholar : PubMed/NCBI
24	Jiang MM, Mai ZT, Wan SZ, Chi YM, Zhang X, Sun BH and Di QG: Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis. J Cancer Res Clin Oncol. 144:667–674. 2018. View Article : Google Scholar : PubMed/NCBI
25	Cortés-López M and Miura P: Emerging functions of circular RNAs. Yale J Biol Med. 89:527–537. 2016.
26	Gil J, Ramsey D, Pawlowski P, Szmida E, Leszczynski P, Bebenek M and Sasiadek MM: Interdependence between an expression of the ATG9A gene and the BAX gene in colorectal cancer. J Biol Regul Homeost Agents. 33:183–185. 2019.PubMed/NCBI
27	Claude-Taupin A, Fonderflick L, Gauthier T, Mansi L, Pallandre JR, Borg C, Perez V, Monnien F, Algros MP, Vigneron M, et al: ATG9A is overexpressed in triple negative breast cancer and its in vitro extinction leads to the inhibition of pro-cancer phenotypes. Cells. 7:2482018. View Article : Google Scholar : PubMed/NCBI
28	Lyu DB and Huang SL: The emerging role and clinical implication of human exonic circular RNA. Rna Biol. 14:1000–1006. 2017. View Article : Google Scholar : PubMed/NCBI
29	Kulcheski FR, Christoff AP and Margis R: Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 238:42–51. 2016. View Article : Google Scholar : PubMed/NCBI
30	Li X, Yang B, Ren H, Xiao T, Zhang L, Li L, Li M, Wang X, Zhou H and Zhang W: Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p. Cell Death Dis. 10:9532019. View Article : Google Scholar : PubMed/NCBI
31	Zhou Y, Zheng X, Xu B, Chen L, Wang Q, Deng H and Jiang J: Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183/PDPK1 signaling pathway. Biochem Biophys Res Commun. 508:527–535. 2019. View Article : Google Scholar : PubMed/NCBI
32	Sun X, Xiao D, Xu T and Yuan Y: miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5. Future Oncol. 12:2701–2712. 2016. View Article : Google Scholar : PubMed/NCBI
33	Lu K, Wang J, Song Y, Zhao S, Liu H, Tang D, Pan B, Zhao H and Zhang Q: miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. Oncol Rep. 34:995–1002. 2015. View Article : Google Scholar : PubMed/NCBI
34	Fan JC, Zeng F, Le YG and Xin L: LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p. J Cell Biochem. 119:6391–6397. 2018. View Article : Google Scholar : PubMed/NCBI
35	Li X, Han X, Wei P, Yang J and Sun J: Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Cancer Biol Ther. 21:452–462. 2020. View Article : Google Scholar : PubMed/NCBI
36	Su C, Shi K, Cheng X, Han Y, Li Y, Yu D and Liu Z: Long noncoding RNA LINC00472 inhibits proliferation and promotes apoptosis of lung adenocarcinoma cells via regulating miR-24-3p/DEDD. Technol Cancer Res Treat. 17:15330338187904902018. View Article : Google Scholar : PubMed/NCBI
37	Liu H, Wang X, Wang ZY and Li L: Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR-24-3p and targeting fibroblast growth factor 11. J Cell Physiol. 235:4520–4529. 2020. View Article : Google Scholar : PubMed/NCBI
38	Zhang W, Wang J, Chai R, Zhong G, Zhang C, Cao W, Yan L, Zhang X and Xu Z: Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas. Onco Targets Ther. 11:4537–4545. 2018. View Article : Google Scholar : PubMed/NCBI
39	Linford A, Yoshimura S, Nunes Bastos R, Langemeyer L, Gerondopoulos A, Rigden DJ and Barr FA: Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction stability in migrating cells. Dev Cell. 22:952–966. 2012. View Article : Google Scholar : PubMed/NCBI
40	Wang M and Petersen NO: Lipid-coated gold nanoparticles promote lamellar body formation in A549 cells. Biochim Biophys Acta. 1831:1089–1097. 2013. View Article : Google Scholar : PubMed/NCBI
41	Schaaij-Visser TB, de Wit M, Lam SW and Jiménez CR: The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim Biophys Acta. 1834:2242–2258. 2013. View Article : Google Scholar : PubMed/NCBI
42	Zhang L, Huang M and Harsay E: A chemical genetic screen for modulators of exocytic transport identifies inhibitors of a transport mechanism linked to GTR2 function. Eukaryot Cell. 9:116–126. 2010. View Article : Google Scholar : PubMed/NCBI